Cannabidiol efficacy and clobazam status: A systematic review and meta‐analysis,Epilepsia

当前位置： X-MOL 学术 › Epilepsia › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Cannabidiol efficacy and clobazam status: A systematic review and meta‐analysis
Epilepsia ( IF 6.6 ) Pub Date : 2020-05-26 , DOI: 10.1111/epi.16546
Simona Lattanzi ₁ , Eugen Trinka _{2,

3,

4} , Pasquale Striano ₅ , Gaetano Zaccara ₆ , Cinzia Del Giovane ₇ , Raffaele Nardone _{2,

8} , Mauro Silvestrini ₁ , Francesco Brigo _{8,

9}

Affiliation

To evaluate the potential impact of concomitant clobazam (CLB) use on the efficacy of cannabidiol (CBD) treatment in patients with Dravet syndrome and Lennox‐Gastaut syndrome using meta‐analytical techniques.

中文翻译：